Factor XII 46C → T gene polymorphism in Chilean subjects with coronary artery disease and controls

Medical Principles and Practice

Volumn 18, Issue 2, 2009, Pages 137-142

  Caamaño, José ^a,b   Jaramillo, Priscilla C ^a   Lanas, Cecilia ^b   Lanas, Fernando ^b   Salazar, Luis A ^a,b  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

C46T polymorphism; Coagulation factors; Coronary artery disease; F12 gene

Indexed keywords

BLOOD CLOTTING FACTOR 12;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CHILE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE SIZE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILE; CORONARY ARTERY DISEASE; FACTOR XII; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 60149104235     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189812     Document Type: Article

References (30)

1. Lanas F, Avezum A, Bautista LE, Díaz R, Luna M, Islam S, Yusuf S, INTERHEART Investigators in Latin America: Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007;115: 1067-1074.
2. Mayer B, Erdmann J, Schunkert H: Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol 2007;96:1-7.
3. Jaramillo PC, Muñoz A, Lanas C, Lanas F, Salazar LA: Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2006;371:102-106.
4. Jaramillo PC, Lanas C, Lanas F, Salazar LA: -786T>C polymorphism of the endothelial nitric oxide synthase gene in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2008;387:105-108.
5. Pare G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, Engert JC, Hudson TJ, Gaudet D: Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet 2007;80:673-682.
6. Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RD: Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta 2000;300:139-149.
7. Wu A, Tsongalis G: Correlation of polymorphism to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001;87:1361-1366.
8. Taymaz H, Erarslan S, Oner ET, Alkan T, Aǧirbaşli M, Kirdar B: Sequence variations within the genes related to hemostatic imbalance and their impact on coronary artery disease in Turkish population. Thromb Res 2007;119:55-62.
9. Martinelli N, Trabetti E, Pinotti M, Olivieri O, Sandri M, Friso S, Pizzolo F, Bozzini C, Caruso PP, Cavallari U, Cheng S, Pignatti PF, Bernardi F, Corrocher R, Girelli D: Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. PLoS ONE 2008;3:e1523.
10. Zito F, Lowe G, Rumley A, McMahon A, Humphries S: Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. Atherosclerosis 2002;165:153-158.
11. Santamaría A, Mateo J, Tirado I, Oliver A, Belvís R, Martí-Fábregas J, Felices R, Soria JM, Souto JC, Fontcuberta J: Homozygosity of the T allele of the 46 C>T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. Stroke 2004;35:1795-1799.
12. Santamaría A, Martinez-Rubio A, Mateo J, Tirado I, Soria J, Fontcuberta J: Homozygosity of the T allele of the 46 C>T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population. Haematologica 2004;89: 878-879.
13. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, Felices R, Borrell M, Fontcuberta J: Association after linkage analysis indicates that homozygosity for the 46C>T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004;91:899-904.
14. Endler G, Mannhalter C, Sunder-Plassmann H, Lalouschek W, Kapiotis S, Exner M, Jordanova N, Meier S, Kunze F, Wagner O, Huber K: Homozygosity for the C>T polymorphism at nucleotide 46 in the 5′untraslated region of the factor XII gene protects from development of acute coronary syndrome. Br J Haematol 2001;115:1007-1009.
15. Endler G, Exner M, Mannhalter C, Meier S, Ruzicka K, Handler S, Panzer S, Wagner O, Quehenberger P: A common C->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity. Thromb Res 2001;101:255-260.
16. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD: Optimized procedure DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 1998;44:1748-1750.
17. Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, Miller GJ: Epidemiological and genetic association of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 2000;102:2058-2062.
18. Orth M, Westphal S, Dierkes J, Luley C, Schlatterer K: Rapid factor XII (46 C>T) genotyping by fluorescence resonance energy transfer in patients with coronary artery disease or thrombophilia. Clin Chem 2001;47:1117-1119.
19. Colhoun H, Zito F, Chan N, Rubens M, Fuler J, Humphries S: Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type I diabetes and healthy subjects. Atherosclerosis 2002;163:363-369.
20. Kohler H, Futers T, Grant P: FXII (46C>T) polymorphism and in vivo generation of FXII activity-gene frequencies and relationship in patients with coronary artery disease. Thromb Haemost 1999;81:745-747.
21. Bach J, Endler G, Winkelmann BR, Boehm BO, Maerz W, Mannhalter C, Hellstern P: Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk. J Thromb Haemost 2008;6: 291-296.
22. Roldán V, Corral J, Marín F, Pineda J, Vicente V, González-Conejero R: Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction. Thromb Haemost 2005;94:1294-1299.
23. Soria JM, Almasy L, Souto JC, Bacq D, Buil A, Faure A, Martínez-Marchán E, Mateo J, Borrell M, Stone W, Lathrop M, Fontcuberta J, Blangero J: A quantitative-trait locus in the human factor XII gene influences both plasma factor levels and susceptibility to thrombotic disease. Am J Hum Genet 2002;70:567-574.
24. Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, Daurès JP, Quéré I, Dauzat M, Marès P, Gris JC: Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy. J Thromb Haemost 2007;5:700-707.
25. Reuner KH, Jenetzky E, Aleu A, Litfin F, Mellado P, Kloss M, Jüttler E, Grau AJ, Rickmann H, Patscheke H, Lichy C: Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology 2008;70:129-132.
26. Bach J, Endler G, Mannhalter C, Hellstern P: Coagulation factor XII (FXII) activity, activated factor XII, distribution of factor XII C46T gene polymorphism and coronary risk: reply to a rebuttal. J Thromb Haemost 2008;6:1055-1056.
27. Miller CH, Hooper C: Phenotypic and genotypic differences in factor XII between African Americans and Caucasians. J Thromb Haemost 2007;5:1981-1982.
28. Szolnoki Z: Evaluation of the interactions of common genetic mutations in stroke. Methods Mol Med 2005;104:241-250.
29. Kohler HP, Carter AM, Stickland MH, Grant PJ: Levels of activated FXII in survivors of myocardial infarction - Association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 1998;79:14-18.
30. Prusa R, Zadina J, Bronský J: Activated factor XII in patients with hyperglycaemia and dyslipidaemia. Vnitr Lek 2004;50:917-922.